Cargando…

Reversible Ocular Toxicity of Oxaliplatin: A Case Report

Oxaliplatin, a platinum-based chemotherapy agent, is commonly used in the treatment of various malignancies. Common adverse effects involve neurological, hematological, gastrointestinal system, and hypersensitivity, and rarely ocular changes have also been reported. We describe the case of a 71-year...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noor, Arish, Desai, Aakash, Singh, Meghana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6605969/ https://www.ncbi.nlm.nih.gov/pubmed/31293842 http://dx.doi.org/10.7759/cureus.4582

Ejemplares similares

Oxaliplatin-Related Ocular Toxicity
por: Mesquida, Marina, et al.
Publicado: (2010)

Breast Cancer Metastasis Masquerading as Primary Colon and Gastric Cancer: A Case Report
por: Noor, Arish, et al.
Publicado: (2020)

Amaurosis Fugax: A Rare Oxaliplatin-Induced Ocular Toxicity − A Report of Three Cases
por: Tunio, Mutahar Ali, et al.
Publicado: (2022)

Takotsubo cardiomyopathy in cancer patients
por: Desai, Aakash, et al.
Publicado: (2019)

Case Report: Favorable Response and Manageable Toxicity to the Combination of Camrelizumab, Oxaliplatin, and Oral S-1 in a Patient With Advanced Epstein–Barr Virus-Associated Gastric Cancer
por: Lv, Wanrui, et al.
Publicado: (2022)

Secondary Immune Thrombocytopenic Purpura in Renal Cell Cancer: A Paraneoplastic Syndrome
por: Noor, Arish, et al.
Publicado: (2019)

Bevacizumab Combined With Oxaliplatin/Capecitabine in Patient With Refractory and Recurrent Mucinous Adenocarcinoma of the Appendix: A Case Report
por: Liu, Wenzhi, et al.
Publicado: (2019)

Oxaliplatin toxicity presenting as a liver nodule – case report
por: Alexandrino, Henrique, et al.
Publicado: (2015)

Idiosyncratic Reaction with Cytokine Storm Associated with Oxaliplatin
por: Dembla, Vikas
Publicado: (2016)

Ocular Toxicity of Belantamab Mafodotin, an Oncological Perspective of Management in Relapsed and Refractory Multiple Myeloma
por: Wahab, Ahsan, et al.
Publicado: (2021)

Fluorouracil/folinic acid/oxaliplatin: Various toxicities: 2 case reports
Publicado: (2021)

Case Report: Ocular Manifestations and Treatments of Ciliary Body Involvement by Lymphoma
por: Di, Yu, et al.
Publicado: (2021)

2677. Infection-Related Outcomes in Patients With Malignancy-Related Febrile Neutropenia: A National Perspective
por: Noor, Arish, et al.
Publicado: (2019)

A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases
por: Feng, Ai-Wei, et al.
Publicado: (2022)

Prevention of Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis
por: Peng, Siyu, et al.
Publicado: (2022)

Papillary renal neoplasm with reverse polarity: A case report
por: Xing, Chengjuan, et al.
Publicado: (2023)

Small bowel edema and lymphocytic duodenitis as severe reversible gastrointestinal toxicity of selpercatinib in RET fusion–positive non–small cell lung cancer: a case report
por: Scattolin, Daniela, et al.
Publicado: (2023)

Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection
por: Yu, Yuanyuan, et al.
Publicado: (2021)

Long-term Response to Vismodegib in a Patient with Gorlin-Goltz Syndrome: A Case Report and Review of Pathological Mechanisms Involved
por: Kesireddy, Meghana, et al.
Publicado: (2019)

Oxaliplatin-Induced Pulmonary Toxicity in Gastrointestinal Malignancies: Two Case Reports and Review of the Literature
por: Moskovitz, Mor, et al.
Publicado: (2015)

Rare Dihydropyrimidine Dehydrogenase Variants and Toxicity by Floropyrimidines: A Case Report
por: Palmirotta, Raffaele, et al.
Publicado: (2019)

Desferrioxamine-related ocular toxicity: A case report
por: Simon, Sumu, et al.
Publicado: (2012)

Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma
por: Liang, Rong, et al.
Publicado: (2021)

A Study on Mesoporous Silica Loaded With Novel Photosensitizers HCE6 and Oxaliplatin for the Treatment of Cholangiocarcinoma
por: Zhang, Pei-Jian, et al.
Publicado: (2021)

Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
por: Zhou, Yue, et al.
Publicado: (2022)

Case of an Incidentally Found Squamous Cell Carcinoma of the Tonsil: Are We Underestimating Its Incidence?
por: Parsi, Meghana
Publicado: (2019)

Case Report: Reversal of Hyaluronic Acid Rectal Wall Infiltration with Hyaluronidase
por: Hong, Anne, et al.
Publicado: (2022)

Toxic epidermal necrosis associated with afatinib: A case report and literature review
por: Yang, Wei, et al.
Publicado: (2023)

Chordoma: A Case Report and Review of Literature
por: Noor, Arish, et al.
Publicado: (2020)

Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance Study
por: Yu, Zaoqin, et al.
Publicado: (2021)

Evaluation of oxaliplatin-induced pulmonary toxicity in rats
por: Kalemci, Serdar, et al.
Publicado: (2019)

Application of IVIM-DWI in Detecting the Tumor Vasculogenic Mimicry Under Antiangiogenesis Combined With Oxaliplatin Treatment
por: Liang, Jianye, et al.
Publicado: (2020)

Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma
por: Han, Jiayi, et al.
Publicado: (2020)

MiR-454-3p Promotes Oxaliplatin Resistance by Targeting PTEN in Colorectal Cancer
por: Qian, Xiao-Lan, et al.
Publicado: (2021)

Corrigendum: Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
por: Zhou, Yue, et al.
Publicado: (2022)

Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma
por: Kang, Xiaofeng, et al.
Publicado: (2022)

Oxaliplatin-induced haematological toxicity and splenomegaly in mice
por: Lees, Justin G., et al.
Publicado: (2020)

Rare papillary renal neoplasm with reverse polarity: A case report and review of the literature
por: Tu, Xi, et al.
Publicado: (2023)

Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada
por: Attard, C.L., et al.
Publicado: (2010)

Case report: Zanubrutinib-induced dermatological toxicities: A single-center experience and review
por: Wang, Lingling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9kcdk1p67sm1dfo02n6go366lm